Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 47335-410

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 47335-410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sumatriptan-and-naproxen-figure1 (Spl Sumatriptan And Naproxen Figure1)

A line graph titled 'Percentage of Adult Patients with Initial Headache Pain Relief within 2 Hours' showing percentage of patients with relief over hours postdose for four groups: Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg, Sumatriptan 85 mg, Naproxen Sodium 500 mg, and Placebo. The y-axis represents percentage of patients with relief (0 to 100%), and the x-axis shows time in hours postdose (0 to 2). The combination treatment demonstrates the highest percentage of patients with initial headache pain relief over time compared to individual treatments and placebo.*

FDA Label Image

Spl-sumatriptan-and-naproxen-figure2 (Spl Sumatriptan And Naproxen Figure2)

A line graph titled "Estimated Probability of Adults Taking a Rescue Medication over the 24 Hours following the First Dose" showing the percentage of patients taking rescue medication over time (hours postdose). Four lines represent Placebo, Naproxen, Sumatriptan, and Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg, with the combination showing the lowest percentage, followed by Sumatriptan, Naproxen, and Placebo having the highest percentage over 24 hours.*

FDA Label Image

Spl-sumatriptan-and-naproxen-label (Spl Sumatriptan And Naproxen Label)

Label of Sumatriptan and Naproxen Sodium Tablets 85 mg/500 mg film-coated tablets by Sun Pharmaceutical Industries, Inc. The label includes the NDC 47335-410-22 and indicates a package containing 9 tablets. The label also instructs pharmacists to dispense the medication guide separately to each patient.*

FDA Label Image

Spl-sumatriptan-and-naproxen-naproxen-sodium-str (Spl Sumatriptan And Naproxen Naproxen Sodium Str)

Chemical structure diagram of the active ingredient Naproxen Sodium, showing its molecular arrangement including the naphthalene ring with methoxy and sodium carboxylate groups.*

FDA Label Image

Spl-sumatriptan-and-naproxen-sumatriptan-str (Spl Sumatriptan And Naproxen Sumatriptan Str)

Chemical structure diagram of Sumatriptan and Naproxen Sodium, the active ingredients in the product. The image shows molecular components including nitrogen, sulfur, and carboxyl groups connected by various bonds, characteristic of the chemical formulas of these compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.